Using Thioflavin S staining, we confirmed that the levels of tau ‘amyloid’ was indeed reduced in Variant 4 seeded with AD-tau relative to Variant 5 and parent P301L tau seeded with AD-tau from Patient B (Additional file 1: Fig. S5). The gene discussed is MAPT; the disease is Alzheimer disease.